DREAMM13

A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function

Arms / Cohorts

Part 1, Group 1:Patients with Normal Hepatic Function

Accepting patients

Part 1, Group 2:Patients with Moderate Hepatic Impairment

Accepting patients

Part 2, Group 3:Patients with Severe Hepatic Impairment

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.